Centronuclear Myopathy in Labrador Retrievers: A Recent Founder Mutation in the PTPLA Gene Has Rapidly Disseminated Worldwide

PLoS ONE

Volumn 7, Issue 10, 2012, Pages

  Maurer, Marie ^a,b   Mary, Jérôme ^a,b,c   Guillaud, Laurent ^a,b   Fender, Marilyn ^d   Pelé, Manuel ^a,b   Bilzer, Thomas ^e   Olby, Natasha ^f   Penderis, Jacques ^g   Shelton, G Diane ^h   Panthier, Jean Jacques ^a,b,i   Thibaud, Jean Laurent ^a   Barthélémy, Inès ^a   Aubin Houzelstein, Geneviève ^a,b   Blot, Stéphane ^a   Hitte, Christophe ^j   Tiret, Laurent ^a,b  

^a UNIVERSITÉ PARIS EST CRÉTEIL   (France)

^b CEMAGREF   (France)

^c Antagene ^*  (France)

^d CNM Project   (United States)

^e HEINRICH HEINE UNIVERSITY   (Germany)

^f NORTH CAROLINA STATE UNIVERSITY   (United States)

^g UNIVERSITY OF GLASGOW   (United Kingdom)

^h UNIVERSITY OF CALIFORNIA   (United States)

ⁱ CNRS   (France)

^j UNIVERSITÉ DE RENNES 1   (France)

more..

Author keywords

[No Author keywords available]

Indexed keywords

GENOMIC DNA;

ALLELE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CENTRONUCLEAR MYOPATHY; CONTROLLED STUDY; DNA EXTRACTION; DOG; GENE; GENE MUTATION; GENOTYPE; HAPLOTYPE; HETEROZYGOTE; HISTOPATHOLOGY; LABRADOR RETRIEVER; MUSCLE BIOPSY; NONHUMAN; PATHOPHYSIOLOGY; PROTEIN TYROSINE PHOSPHATASE LIKE A GENE; SEQUENCE ANALYSIS; SINGLE NUCLEOTIDE POLYMORPHISM;

ALLELES; ANIMALS; DOG DISEASES; DOGS; FOUNDER EFFECT; GENES, RECESSIVE; MUTATION; MYOPATHIES, STRUCTURAL, CONGENITAL; PHENOTYPE; PROTEIN TYROSINE PHOSPHATASES;

ANIMALIA;

EID: 84867150505     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0046408     Document Type: Article

References (42)

1. Jungbluth H, Wallgren-Pettersson C, Laporte J, (2008) Centronuclear (myotubular) myopathy. Orphanet J Rare Dis 3: 26.
2. Romero NB, Bitoun M, (2011) Centronuclear Myopathies. Semin Pediatr Neurol 18: 250-256.
3. Laporte J, Hu LJ, Kretz C, Mandel JL, Kioschis P, et al. (1996) A gene mutated in X-linked myotubular myopathy defines a new putative tyrosine phosphatase family conserved in yeast. Nat Genet 13: 175-182.
4. Bitoun M, Maugenre S, Jeannet PY, Lacene E, Ferrer X, et al. (2005) Mutations in dynamin 2 cause dominant centronuclear myopathy. Nat Genet 37: 1207-1209.
5. Jungbluth H, Zhou H, Sewry CA, Robb S, Treves S, et al. (2007) Centronuclear myopathy due to a de novo dominant mutation in the skeletal muscle ryanodine receptor (RYR1) gene. Neuromuscul Disord 17: 338-345.
6. Nicot AS, Toussaint A, Tosch V, Kretz C, Wallgren-Pettersson C, et al. (2007) Mutations in amphiphysin 2 (BIN1) disrupt interaction with dynamin 2 and cause autosomal recessive centronuclear myopathy. Nat Genet 39: 1134-1139.
7. Tosch V, Rohde HM, Tronchere H, Zanoteli E, Monroy N, et al. (2006) A novel PtdIns3P and PtdIns(3,5)P2 phosphatase with an inactivating variant in centronuclear myopathy. Hum Mol Genet 15: 3098-3106.
8. Wilmshurst JM, Lillis S, Zhou H, Pillay K, Henderson H, et al. (2010) RYR1 mutations are a common cause of congenital myopathies with central nuclei. Ann Neurol 68: 717-726.
9. Bevilacqua JA, Monnier N, Bitoun M, Eymard B, Ferreiro A, et al. (2011) Recessive RYR1 mutations cause unusual congenital myopathy with prominent nuclear internalization and large areas of myofibrillar disorganization. Neuropathol Appl Neurobiol 37: 271-284.
10. Blot S, Tiret L, Devillaire AC, Fardeau M, Dreyfus PA, (2002) Phenotypic description of a canine centronuclear myopathy. J Neurol Sci 199: S9.
11. Tiret L, Blot S, Kessler JL, Gaillot H, Breen M, et al. (2003) The cnm locus, a canine homologue of human autosomal forms of centronuclear myopathy, maps to chromosome 2. Hum Genet 113: 297-306 Epub 2003 Jul 2023.
12. Pelé M, Tiret L, Kessler JL, Blot S, Panthier JJ, (2005) SINE exonic insertion in the PTPLA gene leads to multiple splicing defects and segregates with the autosomal recessive centronuclear myopathy in dogs. Hum Mol Genet 14: 1417-1427.
13. Kramer JW, Hegreberg GA, Bryan GM, Meyers K, Ott RL, (1976) A muscle disorder of Labrador retrievers characterized by deficiency of type II muscle fibers. J Am Vet Med Assoc 169: 817-820.
14. McKerrell RE, Anderson JR, Herrtage ME, Littlewood JD, Palmer AC, (1984) Generalised muscle weakness in the Labrador retriever. Vet Rec 115: 276.
15. Watson AD, Farrow BR, Middleton DJ, Smyth JB, (1988) Myopathy in a Labrador retriever. Aust Vet J 65: 226-227.
16. Bley T, Gaillard C, Bilzer T, Braund KG, Faissler D, et al. (2002) Genetic aspects of labrador retriever myopathy. Res Vet Sci 73: 231-236.
17. Gortel K, Houston DM, Kuiken T, Fries CL, Boisvert B, (1996) Inherited myopathy in a litter of Labrador retrievers. Can Vet J 37: 108-110.
18. Olby NJ, Sharp NJ, Anderson LV, Kunkel LM, Bonnemann CG, (2001) Evaluation of the dystrophin-glycoprotein complex, alpha-actinin, dysferlin and calpain 3 in an autosomal recessive muscular dystrophy in Labrador retrievers. Neuromuscul Disord 11: 41-49.
19. McKerrell RE, Braund KG, (1986) Hereditary myopathy in Labrador retrievers: a morphologic study. Vet Pathol 23: 411-417.
20. McKerrell RE, Braund KG, (1987) Hereditary myopathy in Labrador Retrievers: clinical variations. J Small Anim Pract 28: 479-489.
21. Clark LA, Wahl JM, Rees CA, Murphy KE, (2006) Retrotransposon insertion in SILV is responsible for merle patterning of the domestic dog. Proc Natl Acad Sci U S A 103: 1376-1381.
22. Xue Y, Wang Q, Long Q, Ng BL, Swerdlow H, et al. (2009) Human Y chromosome base-substitution mutation rate measured by direct sequencing in a deep-rooting pedigree. Curr Biol 19: 1453-1457.
23. Owczarek-Lipska M, Thomas A, Andre C, Holzer S, Leeb T, (2011) [Frequency of gen defects in selected European Retriever-populations]. Schweiz Arch Tierheilkd 153: 418-420.
24. Lindblad-Toh K, Wade CM, Mikkelsen TS, Karlsson EK, Jaffe DB, et al. (2005) Genome sequence, comparative analysis and haplotype structure of the domestic dog. Nature 438: 803-819.
25. Knapp MC (1995) Retriver Field Trials. In: Ziessow BW, editor. The Official Book of the Labarador Retriever. Neptune City: T.F.H. Publications, Inc. pp. 181-204.
26. Dowling JJ, Gibbs EM, Feldman EL, (2008) Membrane traffic and muscle: lessons from human disease. Traffic 9: 1035-1043.
27. Cowling BS, Toussaint A, Muller J, Laporte J, (2012) Defective membrane remodeling in neuromuscular diseases: insights from animal models. PLoS Genet 8: e1002595.
28. Toussaint A, Cowling BS, Hnia K, Mohr M, Oldfors A, et al. (2011) Defects in amphiphysin 2 (BIN1) and triads in several forms of centronuclear myopathies. Acta Neuropathol (Berl) 121: 253-266.
29. Hnia K, Tronchere H, Tomczak KK, Amoasii L, Schultz P, et al. (2011) Myotubularin controls desmin intermediate filament architecture and mitochondrial dynamics in human and mouse skeletal muscle. The Journal of clinical investigation 121: 70-85.
30. Razzaq A, Robinson IM, McMahon HT, Skepper JN, Su Y, et al. (2001) Amphiphysin is necessary for organization of the excitation-contraction coupling machinery of muscles, but not for synaptic vesicle endocytosis in Drosophila. Genes & development 15: 2967-2979.
31. Al-Qusairi L, Weiss N, Toussaint A, Berbey C, Messaddeq N, et al. (2009) T-tubule disorganization and defective excitation-contraction coupling in muscle fibers lacking myotubularin lipid phosphatase. Proc Natl Acad Sci U S A 106: 18763-18768.
32. Shen J, Yu WM, Brotto M, Scherman JA, Guo C, et al. (2009) Deficiency of MIP/MTMR14 phosphatase induces a muscle disorder by disrupting Ca(2+) homeostasis. Nat Cell Biol 11: 769-776.
33. Dowling JJ, Vreede AP, Low SE, Gibbs EM, Kuwada JY, et al. (2009) Loss of myotubularin function results in T-tubule disorganization in zebrafish and human myotubular myopathy. PLoS Genet 5: e1000372.
34. Cowling BS, Toussaint A, Amoasii L, Koebel P, Ferry A, et al. (2011) Increased expression of wild-type or a centronuclear myopathy mutant of dynamin 2 in skeletal muscle of adult mice leads to structural defects and muscle weakness. The American journal of pathology 178: 2224-2235.
35. Blondeau F, Laporte J, Bodin S, Superti-Furga G, Payrastre B, et al. (2000) Myotubularin, a phosphatase deficient in myotubular myopathy, acts on phosphatidylinositol 3-kinase and phosphatidylinositol 3-phosphate pathway. Hum Mol Genet 9: 2223-2229.
36. Fidzianska A, Goebel HH, (1994) Aberrant arrested in maturation neuromuscular junctions in centronuclear myopathy. J Neurol Sci 124: 83-88.
37. Dowling JJ, Joubert R, Low SE, Durban AN, Messaddeq N, et al. (2012) Myotubular myopathy and the neuromuscular junction: a novel therapeutic approach from mouse models. Disease models & mechanisms.
38. Denic V, Weissman JS, (2007) A molecular caliper mechanism for determining very long-chain fatty acid length. Cell 130: 663-677.
39. Ikeda M, Kanao Y, Yamanaka M, Sakuraba H, Mizutani Y, et al. (2008) Characterization of four mammalian 3-hydroxyacyl-CoA dehydratases involved in very long-chain fatty acid synthesis. FEBS Lett 582: 2435-2440.
40. Posse de Chaves E, Sipione S, (2010) Sphingolipids and gangliosides of the nervous system in membrane function and dysfunction. FEBS Lett 584: 1748-1759.
41. Kihara A, Sakuraba H, Ikeda M, Denpoh A, Igarashi Y, (2008) Membrane topology and essential amino acid residues of Phs1, a 3-hydroxyacyl-CoA dehydratase involved in very long-chain fatty acid elongation. The Journal of biological chemistry 283: 11199-11209.
42. Beggs AH, Bohm J, Snead E, Kozlowski M, Maurer M, et al. (2010) MTM1 mutation associated with X-linked myotubular myopathy in Labrador Retrievers. Proc Natl Acad Sci U S A 107: 14697-14702.